Sales & Marketing
UK launch market lobbying

Is the UK an attractive launch market?

Leela Barham tries to cut through the lobbying to identify objective measures of the attractiveness of the UK market for launching new medicines. 

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

R&D